Skip to Content
Merck
CN
  • In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog.

In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog.

Journal of neuroscience methods (2011-09-24)
Vassiliy Tsytsarev, Konstantin I Maslov, Junjie Yao, Archana R Parameswar, Alexei V Demchenko, Lihong V Wang
ABSTRACT

Accurately locating epileptic foci has great importance in advancing the treatment of epilepsy. In this study, epileptic seizures were first induced by intracortical injection of 4-aminopyridine in rats. A fluorescent deoxyglucose substitute, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG), was then continuously injected via the tail vein. Brain glucose metabolism was subsequently monitored by fluorescence imaging of 2-NBDG. The initial uptake rate of 2-NBDG at the injection site of 4-aminopyridine significantly exceeded that of the control injection site, which indicated local hypermetabolism induced by seizures. Our results show that 2-NBDG can be used for localizing epileptic foci.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose, ≥97% (HPLC)